Blood Reviews
Volume 21, Issue 6 , Pages 285-299 , November 2007

POEMS syndrome

References 

  1. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine. 1980;59:311–322
  2. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496–2506
  3. Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol. 1983;13:543–555
  4. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984;34:712–720
  5. Scheinker L. Myelom und Nervensystem: uber eine bisher nicht beschrieben mit eigentumlichen Hautveranderungen einhergehende Polyneuritis bei einem plamazellularen Myelom des Sternums. Dtsch Z Nervenheilkd. 1938;147:247–273
  6. Driedger H, Pruzanski W. Plasma cell neoplasia with peripheral polyneuropathy. A study of five cases and a review of the literature. Medicine. 1980;59:301–310
  7. Iwashita H, Ohnishi A, Asada M, Kanazawa Y, Kuroiwa Y. Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma. Neurology. 1977;27:675–681
  8. Crow R. Peripheral neuritis in myelomatosis. Brit Med J. 1956;2:802–804
  9. Driedger H, Pruzanski W. Plasma cell neoplasia with osteosclerotic lesions. A study of five cases and a review of the literature. Arch Intern Med. 1979;139:892–896
  10. Mangalik A, Veliath AJ. Osteosclerotic myeloma and peripheral neuropathy. A case report. Cancer. 1971;28:1040–1045
  11. Evison G, Evans KT. Sclerotic bone deposits in multiple myeloma [letter]. Br J Radiol. 1983;56:145
  12. Reitan JB, Pape E, Fossa SD, Julsrud OJ, Slettnes ON, Solheim OP. Osteosclerotic myeloma with polyneuropathy. Acta Medica Scandinavica. 1980;208:137–144
  13. Morley JB, Schwieger AC. The relation between chronic polyneuropathy and osteosclerotic myeloma. Journal of Neurology, Neurosurgery & Psychiatry. 1967;30:432–442
  14. Mayo CM, Daniels A, Barron KD. Polyneuropathy in the osteosclerotic form of multiple myeloma. Trans Am Neurol Assoc. 1968;93:240–242
  15. Shimpo S, Nishitani H, Tsunermura T. Solitary plasmacytoma with polyneuritis and endocrine disturbance (Jpn). Nippon rinsho. 1968;26:2444–2456
  16. Imawari M, Akatsuka N, Ishibashi M, Beppu H, Suzuki H. Syndrome of plasma cell dyscrasia, polyneuropathy, and endocrine disturbances. Report of a case. Ann Intern Med. 1974;81:490–493
  17. Amiel J, Machover D, Droz J. [Plasma cell dyscrasia with arteriopathy, polyneuropathy, and endocrine syndrome. A Japanese disease in an Italian patient]. [French]. Annales de Medecine Interne. 1975;126(11):745–749
  18. Waldenstrom JG, Adner A, Gydell K, Zettervall O. Osteosclerotic “plasmocytoma” with polyneuropathy, hypertrichosis and diabetes. Acta Med Scand. 1978;203:297–303
  19. Kelly JJ, Kyle RA, Miles JM, Dyck PJ. Osteosclerotic myeloma and peripheral neuropathy. Neurology. 1983;33:202–210
  20. Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. American Journal of Medicine. 1994;97:543–553
  21. Yishay O, Eran E. POEMS syndrome: failure of newly suggested diagnostic criteria to anticipate the development of the syndrome. Am J Hematol. 2005;79:316–318
  22. Mineta M, Hatori M, Sano H, et al. Recurrent Crow-Fukase syndrome associated with increased serum levels of vascular endothelial growth factor: a case report and review of the literature. Tohoku J Exp Med. 2006;210:269–277
  23. Gherardi RK, Belec L, Soubrier M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood. 1996;87:1458–1465
  24. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle & Nerve. 1998;21:1390–1397
  25. Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis & Rheumatism. 1997;40:786–787
  26. Hitoshi S, Suzuki K, Sakuta M. Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease. Internal Medicine. 1994;33:583–587
  27. Rose C, Zandecki M, Copin MC, et al. POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Leukemia. 1997;11:1318–1323
  28. Orefice G, Morra VB, De Michele G, et al. POEMS syndrome: clinical, pathological and immunological study of a case. Neurological Research. 1994;16:477–480
  29. Nakazawa K, Itoh N, Shigematsu H, Koh CS. An autopsy case of Crow-Fukase (POEMS) syndrome with a high level of IL-6 in the ascites. Special reference to glomerular lesions. Acta Pathologica Japonica. 1992;42:651–656
  30. Emile C, Danon F, Fermand JP, Clauvel JP. Castleman disease in POEMS syndrome with elevated interleukin-6 [letter; comment]. Cancer. 1993;71:874
  31. Saida K, Ohta M, Kawakami H, Saida T. Cytokines and myelin antibodies in Crow-Fukase syndrome. Muscle & Nerve. 1996;19:1620–1622
  32. Feinberg L, Temple D, de Marchena E, Patarca R, Mitrani A. Soluble immune mediators in POEMS syndrome with pulmonary hypertension: case report and review of the literature. Critical Reviews in Oncogenesis. 1999;10:293–302
  33. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle & Nerve. 2000;23:1051–1056
  34. Belec L, Mohamed AS, Authier FJ, et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman’s disease. Blood. 1999;93:3643–3653
  35. Belec L, Authier FJ, Mohamed AS, Soubrier M, Gherardi RK. Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman’s disease. Clin Infect Dis. 1999;28:678–679
  36. Bosch EP, Smith BE. Peripheral neuropathies associated with monoclonal proteins. [Review] [63 refs]. Medical Clinics of North America. 1993;77:125–139
  37. Tokashiki T, Hashiguchi T, Arimura K, Eiraku N, Maruyama I, Osame M. Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome. Intern Med. 2003;42:1240–1243
  38. Endo I, Mitsui T, Nishino M, Oshima Y, Matsumoto T. Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome. Internal Medicine. 2002;41:1196–1198
  39. Nakano A, Mitsui T, Endo I, Takeda Y, Ozaki S, Matsumoto T. Solitary plasmacytoma with VEGF overproduction: report of a patient with polyneuropathy. Neurology. 2001;56:818–819
  40. Koga H, Tokunaga Y, Hisamoto T, et al. Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome. Eur J Intern Med. 2002;13:70–74
  41. Gherardi RK, Belec L, Fromont G, et al. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood. 1994;83:2587–2593
  42. Shikama N, Isono A, Otsuka Y, Terano T, Hirai A. A case of POEMS syndrome with high concentrations of interleukin-6 in pericardial fluid. J Intern Med. 2001;250:170–173
  43. Gherardi RK, Chouaib S, Malapert D, Belec L, Intrator L, Degos JD. Early weight loss and high serum tumor necrosis factor-alpha levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome. Annals of Neurology. 1994;35:501–505
  44. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome [letter]. Lancet. 1996;347:702
  45. Scarlato M, Previtali SC, Carpo M, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain. 2005;128:1911–1920
  46. Loeb JM, Hauger PH, Carney JD, Cooper AD. Refractory ascites due to POEMS syndrome. Gastroenterology. 1989;96:247–249
  47. Arimura K. [Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome]. [Japanese]. Rinsho Shinkeigaku Clinical Neurology. 1999;39:84–85
  48. Saida K, Kawakami H, Ohta M, Iwamura K. Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle & Nerve. 1997;20:486–492
  49. Michizono K, Umehara F, Hashiguchi T, et al. Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome. Neurology. 2001;56:807–810
  50. Bryce AH, Ketterling RP, Gertz MA, et al. Cytogenetic analysis using multiple myeloma targets in POEMS syndrome. Proceedings of American Society of Oncology Meeting. Chicago, IL; 2007.
  51. Soubrier M, Labauge P, Jouanel P, Viallard JL, Piette JC, Sauvezie B. Restricted use of Vlambda genes in POEMS syndrome. Haematologica. 2004;89:ECR02
  52. Bergouignan FX, Massonnat R, Vital C, et al. Uncompacted lamellae in three patients with POEMS syndrome. Eur Neurol. 1987;27:173–181
  53. Viard JP, Lesavre P, Boitard C, et al. POEMS syndrome presenting as systemic sclerosis. Clinical and pathologic study of a case with microangiopathic glomerular lesions. Am J Med. 1988;84:524–528
  54. Lesprit P, Authier FJ, Gherardi R, et al. Acute arterial obliteration: a new feature of the POEMS syndrome?. Medicine. 1996;75:226–232
  55. Zenone T, Bastion Y, Salles G, et al. POEMS syndrome, arterial thrombosis and thrombocythaemia. Journal of Internal Medicine. 1996;240:107–109
  56. Soubrier M, Guillon R, Dubost JJ, et al. Arterial obliteration in POEMS syndrome: possible role of vascular endothelial growth factor. Journal of Rheumatology. 1998;25:813–815
  57. Bova G, Pasqui AL, Saletti M, Bruni F, Auteri A. POEMS syndrome with vascular lesions: a role for interleukin-1beta and interleukin-6 increase–a case report. Angiology. 1998;49:937–940
  58. Kang K, Chu K, Kim DE, Jeong SW, Lee JW, Roh JK. POEMS syndrome associated with ischemic stroke. Archives of Neurology. 2003;60:745–749
  59. Atsumi T, Kato K, Kurosawa S, Abe M, Fujisaku A. A case of Crow-Fukase syndrome with elevated soluble interleukin-6 receptor in cerebrospinal fluid. Response to double-filtration plasmapheresis and corticosteroids. Acta Haematologica. 1995;94:90–94
  60. Ghandi GY, Basu R, Dispenzieri A, Basu A, Montori V, Brennan MD. Endocrinopathy in POEMS Syndrome: The Mayo Clinic Experience. Mayo Clin Proc; (In press).
  61. Sung JY, Kuwabara S, Ogawara K, Kanai K, Hattori T. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve. 2002;26:189–193
  62. Suarez GA, Dispenzieri A, Gertz MA, Kyle RA. The electrophysiologic findings of the peripheral neuropathy associated with POEMS. Clin Neurophysiol. 2002;113:S9
  63. Vital C, Vital A, Ferrer X, et al. Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. J Peripher Nerv Syst. 2003;8:136–144
  64. Crisci C, Barbieri F, Parente D, Pappone N, Caruso G. POEMS syndrome: follow-up study of a case. Clinical Neurology & Neurosurgery. 1992;94:65–68
  65. Sanada S, Ookawara S, Karube H, et al. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation. Am J Kidney Dis. 2006;47:672–679
  66. Navis GJ, Dullaart RP, Vellenga E, Elema JD, de Jong PE. Renal disease in POEMS syndrome: report on a case and review of the literature. [Review] [25 refs]. Nephrology, Dialysis, Transplantation. 1994;9:1477–1481
  67. Sano M, Terasaki T, Koyama A, Narita M, Tojo S. Glomerular lesions associated with the Crow-Fukase syndrome. Virchows Archiv A, Pathological Anatomy & Histopathology. 1986;409:3–9
  68. Takazoe K, Shimada T, Kawamura T, et al. Possible mechanism of progressive renal failure in Crow-Fukase syndrome [letter]. Clinical Nephrology. 1997;47:66–67
  69. Mizuiri S, Mitsuo K, Sakai K, et al. Renal involvement in POEMS syndrome. Nephron. 1991;59:153–156
  70. Stewart PM, McIntyre MA, Edwards CR. The endocrinopathy of POEMS syndrome. Scott Med J. 1989;34:520–522
  71. Nakamoto Y, Imai H, Yasuda T, Wakui H, Miura AB. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome. Nephrology, Dialysis, Transplantation. 1999;14:2370–2378
  72. Fukatsu A, Ito Y, Yuzawa Y, et al. A case of POEMS syndrome showing elevated serum interleukin 6 and abnormal expression of interleukin 6 in the kidney. Nephron. 1992;62:47–51
  73. Mufti GJ, Hamblin TJ, Gordon J. Melphalan-induced pulmonary fibrosis in osteosclerotic myeloma [letter]. Acta Haematologica. 1983;69:140–141
  74. Iwasaki H, Ogawa K, Yoshida H, et al. Crow-Fukase syndrome associated with pulmonary hypertension. Internal Medicine. 1993;32:556–560
  75. Ribadeau-Dumas S, Tillie-Leblond I, Rose C, et al. Pulmonary hypertension associated with POEMS syndrome. [Review] [17 refs]. European Respiratory Journal. 1996;9:1760–1762
  76. Okura H, Gohma I, Hatta K, Imanaka T. Thiamine deficiency and pulmonary hypertension in Crow-Fukase syndrome. Internal Medicine. 1995;34:674–675
  77. Lesprit P, Godeau B, Authier FJ, et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. American Journal of Respiratory & Critical Care Medicine. 1998;157:907–911
  78. Brazis PW, Liesegang TJ, Bolling JP, Kashii S, Trachtman M, Burde RM. When do optic disc edema and peripheral neuropathy constitute poetry?. Survey of Ophthalmology. 1990;35:219–225
  79. Kishimoto S, Takenaka H, Shibagaki R, Noda Y, Yamamoto M, Yasuno H. Glomeruloid hemangioma in POEMS syndrome shows two different immunophenotypic endothelial cells. Journal of Cutaneous Pathology. 2000;27:87–92
  80. Paciocco G, Bossone E, Erba H, Rubenfire M. Reversible pulmonary hypertension in POEMS syndrome–another etiology of triggered pulmonary vasculopathy?. [Review] [17 refs]. Canadian Journal of Cardiology. 2000;16:1007–1012
  81. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004;104:3400–3407
  82. Lewerenz J, Gocht A, Hoeger PH, et al. Multiple vascular abnormalities and a paradoxical combination of vitamin B(12) deficiency and thrombocytosis in a case with POEMS syndrome. J Neurol. 2003;250:1488–1491
  83. Martinez-Lavin M, Vargas AS, Cabre J, et al. Features of hypertrophic osteoarthropathy in patients with POEMS syndrome: a metaanalysis [letter]. Journal of Rheumatology. 1997;24:2267–2268
  84. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore). 1980;59:311–322
  85. Shirabe S, Kishikawa M, Mine M, Miyazaki T, Kuratsune H, Tobinaga K. Crow-Fukase syndrome associated with extramedullary plasmacytoma. [Review] [11 refs]. Japanese Journal of Medicine. 1991;30:64–66
  86. Thajeb P, Chee CY, Lo SF, Lee N. The POEMS syndrome among Chinese: association with Castleman’s disease and some immunological abnormalities. Acta Neurologica Scandinavica. 1989;80:492–500
  87. Papo T, Soubrier M, Marcelin AG, et al. Human herpesvirus 8 infection, Castleman’s disease and POEMS syndrome [letter]. Br J Haematol. 1999;104:932–933
  88. Vital C, Gherardi R, Vital A, et al. Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathologica. 1994;87:302–307
  89. Yang SG, Cho KH, Bang YJ, Kim CW. A case of glomeruloid hemangioma associated with multicentric Castleman’s disease. American Journal of Dermatopathology. 1998;20:266–270
  90. Kobayashi H, Ii K, Sano T, Sakaki A, Hizawa K, Ogushi F. Plasma-cell dyscrasia with polyneuropathy and endocrine disorders associated with dysfunction of salivary glands. American Journal of Surgical Pathology. 1985;9:759–763
  91. Bitter M, Komaiko W, Franklin W. Giant lymph node hyperplasia with osteoblastic bone lesions and the POEMS (Takatsuki’s) syndrome. Cancer. 1985;56:188–194
  92. Lapresle J, Lacroix-Ciaudo C, Reynes M, Madoule P. [Crow-Fukase syndrome (POEMS syndrome) and osseous mastocytosis secondary to Castleman’s angiofollicular lymphoid hyperplasia]. [French]. Revue Neurologique. 1986;142:731–737
  93. Gherardi R, Baudrimont M, Kujas M, et al. Pathological findings in three non-Japanese patients with the POEMS syndrome. Virchows Arch A Pathol Anat Histopathol. 1988;413:357–365
  94. Dworak O, Tschubel K, Zhou H, Meybehm M. [Angiofollicular lymphatic hyperplasia with plasmacytoma and polyneuropathy: a case report with immunohistochemical study]. [German]. Klinische Wochenschrift. 1988;66:591–595
  95. Rolon PG, Audouin J, Diebold J, Rolon PA, Gonzalez A. Multicentric angiofollicular lymph node hyperplasia associated with a solitary osteolytic costal IgG lambda myeloma. POEMS syndrome in a South American (Paraguayan) patient. Pathology, Research & Practice. 1989;185:468–475
  96. Carcaterra A, Santini R, Sozzi G, Zuccoli E. [Crow-Fukase syndrome (POEMS syndrome). The first Italian presentation of a case and review of the literature]. [Review] [33 refs] [Italian]. Giornale Italiano di Dermatologia e Venereologia. 1990;125:97–103
  97. Chan JK, Fletcher CD, Hicklin GA, Rosai J. Glomeruloid hemangioma. A distinctive cutaneous lesion of multicentric Castleman’s disease associated with POEMS syndrome. Am J Surg Pathol. 1990;14:1036–1046
  98. Munoz G, Geijo P, Moldenhauer F, Perez-Moro E, Razquin J, Piris MA. Plasmacellular Castleman’s disease and POEMS syndrome. Histopathology. 1990;17:172–174
  99. Gherardi RK, Malapert D, Degos JD. Castleman disease-POEMS syndrome overlap [letter; comment]. Annals of Internal Medicine. 1991;114:520–521
  100. Myers BM, Miralles GD, Taylor CA, Gastineau DA, Pisani RJ, Talley NJ. POEMS syndrome with idiopathic flushing mimicking carcinoid syndrome. American Journal of Medicine. 1991;90:646–648
  101. Coto V, Auletta M, Oliviero U, et al. POEMS syndrome: an Italian case with diagnostic and therapeutic implications. Annali Italiani di Medicina Interna. 1991;6:416–419
  102. Bosco J, Pathmanathan R. POEMS syndrome, osteosclerotic myeloma and Castleman’s disease: a case report. Australian & New Zealand Journal of Medicine. 1991;21:454–456
  103. Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P, Lotz M. Castleman’s disease in POEMS syndrome with elevated interleukin-6 [see comments]. Cancer. 1992;69:2697–2703
  104. Judge MR, McGibbon DH, Thompson RP. Angioendotheliomatosis associated with Castleman’s lymphoma and POEMS syndrome. Clinical & Experimental Dermatology. 1993;18:360–362
  105. Del Rio R, Alsina M, Monteagudo J, et al. POEMS syndrome and multiple angioproliferative lesions mimicking generalized histiocytomas. Acta Dermato Venereologica. 1994;74:388–390
  106. Bhatia M, Maheshwari MC. Angiofollicular lymphoid hyperplasia presenting as POEMS syndrome. Journal of the Association of Physicians of India. 1994;42:751–752
  107. Adelman HM, Cacciatore ML, Pascual JF, Mike JM, Alberts WM, Wallach PM. Case report: Castleman disease in association with POEMS. American Journal of the Medical Sciences. 1994;307:112–114
  108. Pareyson D, Marazzi R, Confalonieri P, Mancardi GL, Schenone A, Sghirlanzoni A. The POEMS syndrome: report of six cases. Italian Journal of Neurological Sciences. 1994;15:353–358
  109. Ku A, Lachmann E, Tunkel R, Nagler W. Severe polyneuropathy: initial manifestation of Castleman’s disease associated with POEMS syndrome. Archives of Physical Medicine & Rehabilitation. 1995;76:692–694
  110. Huang CC, Chu CC. Poor response to intravenous immunoglobulin therapy in patients with Castleman’s disease and the POEMS syndrome [letter; comment]. Journal of Neurology. 1996;243:726–727
  111. Chang YJ, Huang CC, Chu CC. Intravenous immunoglobulin therapy in POEMS syndrome: a case report. Chung Hua i Hsueh Tsa Chih Chinese Medical Journal. 1996;58:366–369
  112. Forster A, Muri R. [Recurrent cerebrovascular insult–manifestation of POEMS syndrome?]. [German]. Schweizerische Medizinische Wochenschrift Journal Suisse de Medecine. 1998;128:1059–1064
  113. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. American Journal of Clinical Pathology. 1978;69:86–90
  114. Hineman VL, Phyliky RL, Banks PM. Angiofollicular lymph node hyperplasia and peripheral neuropathy: association with monoclonal gammopathy. Mayo Clinic Proceedings. 1982;57:379–382
  115. Black DA, Forgacs I, Davies DR, Thompson RP. Pseudotumour cerebri in a patient with Castleman’s disease. Postgraduate Medical Journal. 1988;64:217–219
  116. Feigert JM, Sweet DL, Coleman M, et al. Multicentric angiofollicular lymph node hyperplasia with peripheral neuropathy, pseudotumor cerebri, IgA dysproteinemia, and thrombocytosis in women. A distinct syndrome [see comments]. Annals of Internal Medicine. 1990;113:362–367
  117. Menke DM, Tiemann M, Camoriano JK, et al. Diagnosis of Castleman’s disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. American Journal of Clinical Pathology. 1996;105:268–276
  118. Mallory A, Spink WW. Angiomatous lymphoid hamartoma in the retroperitoneum presenting with neurologic signs in the legs. Ann Intern Med. 1968;69:305–308
  119. Anonymous . Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1984. N Engl J Med. 1984;311:388–398
  120. Anonymous . Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-1987. A 59-year-old woman with progressive polyneuropathy and monoclonal gammopathy. New England Journal of Medicine. 1987;316:606–618
  121. Yu GS, Carson JW. Giant lymph-node hyperplasia, plasma-cell type, of the mediastinum, with peripheral neuropathy. Am J Clin Pathol. 1976;66:46–53
  122. Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Human Pathology. 1985;16:162–172
  123. Hineman VL, Phyliky RL, Banks PM. Angiofollicular lymph node hyperplasia and peripheral neuropathy: association with monoclonal gammopathy. Mayo Clin Proc. 1982;57:379–382
  124. Donaghy M, Hall P, Gawler J, et al. Peripheral neuropathy associated with Castleman’s disease. J Neurol Sci. 1989;89:253–267
  125. Ganti AK, Pipinos I, Culcea E, Armitage JO, Tarantolo S. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome. Am J Hematol. 2005;79:206–210
  126. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Modern Pathology. 1992;5:525–530
  127. Allam JS, Kennedy CC, Aksamit TR, Dispenzieri A. Pulmonary Manifestations are Common and Associated with Shortened Survival in POEMS syndrome: A Retrospective Review of 141 patients. Submitted.
  128. Davis L, Drachman D. Myeloma Neuropathy. Arch Neurol. 1972;27:507–511
  129. Philips ED, el-Mahdi AM, Humphrey RL, Furlong MB. The effect of the radiation treatment on the polyneuropathy of multiple myeloma. J Can Assoc Radiol. 1972;23:103–106
  130. Broussolle E, Vighetto A, Bancel B, Confavreux C, Pialat J, Aimard G. P.O.E.M.S. syndrome with complete recovery after treatment of a solitary plasmocytoma. Clin Neurol Neurosurg. 1991;93:165–170
  131. Cabezas-Agricola JM, Lado-Abeal JJ, Otero-Anton E, Sanchez-Leira J, Cabezas-Cerrato J. Hypoparathyroidism in POEMS syndrome [letter]. Lancet. 1996;347:701–702
  132. Wong VA, Wade NK. POEMS syndrome: an unusual cause of bilateral optic disk swelling. American Journal of Ophthalmology. 1998;126:452–454
  133. Hogan WJ, Lacy MQ, Wiseman GA, Fealey RD, Dispenzieri A, Gertz MA. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2001;28:305–309
  134. Rovira M, Carreras E, Blade J, et al. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol. 2001;115:373–375
  135. Jaccard A, Royer B, Bordessoule D, Brouet JC, Fermand JP. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood. 2002;99:3057–3059
  136. Peggs KS, Paneesha S, Kottaridis PD, et al. Peripheral blood stem cell transplantation for POEMS syndrome. Bone Marrow Transplant. 2002;30:401–404
  137. Soubrier M, Ruivard M, Dubost JJ, Sauvezie B, Philippe P. Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome. Bone Marrow Transplant. 2002;30:61–62
  138. Wiesmann A, Weissert R, Kanz L, Einsele H. Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation. Blood. 2002;100:2679–2680
  139. Dispenzieri A, Kyle RA, Lacy MQ, et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood. 2004;103:3960–3963
  140. Takai K, Niikuni K, Kurasaki T. [Successful treatment of POEMS syndrome with high-dose chemotherapy and autologous peripheral blood stem cell transplantation]. Rinsho Ketsueki. 2004;45:1111–1114
  141. Kastritis E, Terpos E, Anagnostopoulos A, Xilouri I, Dimopoulos MA. Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support. Clin Lymphoma Myeloma. 2006;7:73–76
  142. Kuwabara S, Misawa S, Kanai K, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology. 2006;66:105–107
  143. Kojima H, Katsuoka Y, Katsura Y, et al. Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue. Int J Hematol. 2006;84:182–185
  144. Imai N, Kitamura E, Tachibana T, et al. Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy. Intern Med. 2007;46:135–138
  145. Anonymous . Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists’ Collaborative Group. J Clin Oncol. 1998;16:3832–3842
  146. Satoh K, Miura I, Chubachi A, Utsumi S, Imai H, Miura AB. Development of secondary leukemia associated with (1;7)(q10;p10) in a patient with Crow-Fukase syndrome. Internal Medicine. 1996;35:660–662
  147. Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med. 1996;335:91–97
  148. Gertz MA, Lacy MQ, Dispenzieri A, et al. Stem cell transplantation for the management of primary systemic amyloidosis. Am J Med. 2002;113:549–555
  149. Silberstein LE, Duggan D, Berkman EM. Therapeutic trial of plasma exchange in osteosclerotic myeloma associated with the POEMS syndrome. Journal of Clinical Apheresis. 1985;2:253–257
  150. Barrier JH, Le Noan H, Mussini JM, Brisseau JM. Stabilisation of a severe case of P.O.E.M.S. syndrome after tamoxifen administration [letter]. J Neurol Neurosurg Psychiatry. 1989;52:286
  151. Enevoldson TP, Harding AE. Improvement in the POEMS syndrome after administration of tamoxifen [letter]. Journal of Neurology, Neurosurgery & Psychiatry. 1992;55:71–72
  152. Authier FJ, Belec L, Levy Y, et al. All-trans-retinoic acid in POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines. Arthritis & Rheumatism. 1996;39:1423–1426
  153. Sinisalo M, Hietaharju A, Sauranen J, Wirta O. Thalidomide in POEMS syndrome: case report. Am J Hematol. 2004;76:66–68
  154. Matsui H, Udaka F, Kubori T, Oda M, Nishinaka K, Kameyama M. POEMS syndrome demonstrating VEGF decrease by ticlopidine. Intern Med. 2004;43:1082–1083
  155. Sternberg AJ, Davies P, Macmillan C, Abdul-Cader A, Swart S. Strontium-89: a novel treatment for a case of osteosclerotic myeloma associated with life-threatening neuropathy. Br J Haematol. 2002;118:821–824
  156. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood. 2005;106:1135
  157. Straume O, Bergheim J, Ernst P. Bevacizumab therapy for POEMS syndrome. Blood. 2006;107:4972–4973author reply 4973–4
  158. Dispenzieri A, Klein CJ, Mauermann ML. Letter to the editor: Lenalidomide Therapy in a Patient with POEMS Syndrome. Blood In press.
  159. Benito-Leon J, Lopez-Rios F, Rodriguez-Martin FJ, Madero S, Ruiz J. Rapidly deteriorating polyneuropathy associated with osteosclerotic myeloma responsive to intravenous immunoglobulin and radiotherapy. Journal of the Neurological Sciences. 1998;158:113–117
  160. Henze T, Krieger G. Combined high-dose 7S-IgG and dexamethasone is effective in severe polyneuropathy of the POEMS syndrome [letter] [see comments]. Journal of Neurology. 1995;242:482–483
  161. Rotta FT, Bradley WG. Marked improvement of severe polyneuropathy associated with multifocal osteosclerotic myeloma following surgery, radiation, and chemotherapy. Muscle & Nerve. 1997;20:1035–1037
  162. Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med. 1999;341:1565–1571
  163. Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I. Long term melphalan-prednisolone chemotherapy for POEMS syndrome. Journal of Neurology, Neurosurgery & Psychiatry. 1997;63:385–387
  164. Arima F, Dohmen K, Yamano Y, et al. [Five cases of Crow-Fukase syndrome]. [Japanese]. Fukuoka Igaku Zasshi Fukuoka Acta Medica. 1992;83:112–120
  165. Kim SY, Lee SA, Ryoo HM, Lee KH, Hyun MS, Bae SH. Thalidomide for POEMS syndrome. Ann Hematol. 2006;85:545–546

☆ Support in part by the Robert A. Kyle Hematologic Malignancies Fund, Mayo Clinic.

PII: S0268-960X(07)00044-6

doi: 10.1016/j.blre.2007.07.004

Blood Reviews
Volume 21, Issue 6 , Pages 285-299 , November 2007

Article Tools

* Image Usage & Resolution